Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $6.69 Million - $7.4 Million
-150,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $6.77 Million - $8.07 Million
150,000 New
150,000 $7.16 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Toms Capital Investment Management LP Portfolio

Follow Toms Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toms Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Toms Capital Investment Management LP with notifications on news.